...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Exempt Distribution Jan 20

If they are selling shares @ $1.50 us including 1/2 wtFro say 1.40 Us why are investors not jumping all over the ZHCLF @ 50 cents? From what DM said it is the same Cusip number.

Share
New Message
Please login to post a reply